Professor Colin Smith

Professor of Functional Genomics

Qualifications: B.Sc, PhD

Email:
Phone: Work: 01483 68 6937
Room no: 15 AX 02

Office hours

0900-1700 h, Monday-Friday

Further information

Biography

My first degree, in Microbiology, was obtained from the University of Bristol in 1981.
From 1981-1984 I undertook my PhD studies on molecular genetics of Streptomyces in the labs of Prof Keith Chater and Prof Sir David Hopwood at the John Innes Institute, Norwich. My research was focussed on developing RNA methods for Streptomyces and characterisation of gene structure and regulation - using the glycerol catabolic operon as a model system.

I moved back to the University of Bristol (Biochemistry Department) in 1985 to work as a postdoctoral research associate in the lab of Professor Nigel Brown, continuing to dissect regulatory mechanisms controlling the glycerol operon. I took up a Lectureship in Molecular Genetics at UMIST (Manchester) in 1988 and for the next 10 years studied a range of regulatory systems in Streptomyces, most notably the heat-shock response.

From 1999 I started to embrace multidisciplinarity - engaging in collaborative research projects with chemists, mathematicians, engineers, statisticians and computer scientists. From 2001-2002 I undertook a sabbatical in the Control Systems Centre (Dept. Electronics and Electrical Engineering) at UMIST with Dr Olaf Wolkenhauer. Since then my major research areas have been biosynthetic engineering on nonribosomal peptide antibiotics, DNA microarray technology, global analysis of gene expression and characterization of transcriptional regulatory networks.

For the last 10 years I have managed a BBSRC/EC funded microarray/bioinformatics resource at Surrey (formerly at Manchester), principally for the international Streptomyces community. I moved to the University of Surrey in 2003 to take up the new Chair of Functional Genomics, My major areas of research currently revolve around systems level analysis of Streptomyces regulatory networks and of human sleep physiology in the context of global gene expression (monitored from leukocytes).

Research Interests

    A. Systems biology of Streptomyces coelicolor

Our current activities cover two broad inter-related areas:

1. Transcriptional regulatory networks controlling morphological and ‘physiological’ differentiation (e.g. antibiotic production). We are in the process of constructing transcription factor regulatory networks by using a combination of global gene expression profiling and ChIP-on-chip analysis approaches. We have developed experimentally-validated high density arrays (44,000 x 60 mer and 105,000 x 60 mer formats) for this work. In addition to examining the global distribution of RNA polymerase we are currently investigating several transcription factors, including PhoP, CdaR, AbsA2 and DasR (in collaboration with Gilles van Wezel at Leiden University, NL) and AtrA (in collaboration with Kenny McDowall at Leeds University, UK).

2. Non-coding RNA and the primary transcriptome of Streptomyces coelicolor. In recent years it has become clear that small non-coding RNAs play a diverse role in the control of cellular processes in bacteria. We have used our 105K arrays to identify large numbers of small intergenic non coding RNAs, some of which are implicated in controlling morphology and antibiotic production. We are now switching to applying ‘RNA-seq’ to build a comprehensive picture of all non-coding RNAs under a variety of liquid and surface-grown conditions. It is envisaged that the findings of this study will be integrated with the data on transcription factor regulatory networks and that both will ultimately be integrated with the genome scale metabolic network.

Current collaborators:

Internal: Emma Laing, Andrjez Kierzek, Mike Bushell, Claudio Avignone-Rossa

External: Gilles van Wezel (Leiden), David Hodgson (Warwick), Mark Paget (Sussex), Klas Flärdh (Lund) and Kenny McDowall

Current funding from the BBSRC

On-line research resources

We have developed a number of on-line tools for microarray data analysis, genomics and metabolic pathway analysis. Microarrays and a variety of software tools and data resources are available from our website.

    B. Systems level analysis of human sleep physiology

The generic nature of high throughput techniques such as gene expression profiling has led us to develop multidisciplinary collaborations with other groups within FHMS. We are working with Prof Derk-Jan Dijk and others in the Surrey Sleep Research Centre on two major inter-related research contracts:

1. Circadian and homeostatic contributions to physiology, cognition and
genome-wide expression in human and mouse variants of the PER3 VNTR
polymorphism [BBSRC funded since 2008]

2. Cognitive vulnerability following extended wakefulness in defined genotypes:
Effects of sleep duration on sustained attention, executive function, and
novel biomarkers [AFOSR (USA) funded since 2008].

Current collaborators

Derk-Jan Dijk, Simon Archer, Malcolm von Schantz, John Groeger (Cork)

C. Global analysis of gene expression in tumours following chemotherapy. Collaboration with Professor N. Karanjia (Royal Surrey County Hospital), supported by the Liver Cancer Surgery Appeal since 2007.

D. Vitamin D fortification, vitamin D status and global gene expression in leukocytes

A new BBSRC-funded collaboration with Drs Sue Lanham-New and Kath Hart within FHMS: Ergocalciferol (D2) vs. Cholecalciferol (D3) Food Fortification: Comparative Efficiency in Raising 25OHD Status & Mechanisms of Action (D2-D3 Study) [Funded from 2011]

Publications

Journal articles

  • Rico S, Santamaría RI, Yepes A, Rodríguez H, Laing E, Bucca G, Smith CP, Díaz M. (2014) 'Deciphering the regulon of Streptomyces coelicolor AbrC3, a positive response regulator of antibiotic production.'. Appl Environ Microbiol, United States: 80 (8), pp. 2417-2428.

    Abstract

    The atypical two-component system (TCS) AbrC1/C2/C3 (encoded by SCO4598, SCO4597, and SCO4596), comprising two histidine kinases (HKs) and a response regulator (RR), is crucial for antibiotic production in Streptomyces coelicolor and for morphological differentiation under certain nutritional conditions. In this study, we demonstrate that deletion of the RR-encoding gene, abrC3 (SCO4596), results in a dramatic decrease in actinorhodin (ACT) and undecylprodiginine (RED) production and delays morphological development. In contrast, the overexpression of abrC3 in the parent strain leads to a 33% increase in ACT production in liquid medium. Transcriptomic analysis and chromatin immunoprecipitation with microarray technology (ChIP-chip) analysis of the ΔabrC3 mutant and the parent strain revealed that AbrC3 directly controls ACT production by binding to the actII-ORF4 promoter region; this was independently verified by in vitro DNA-binding assays. This binding is dependent on the sequence 5'-GAASGSGRMS-3'. In contrast, the regulation of RED production is not due to direct binding of AbrC3 to either the redZ or redD promoter region. This study also revealed other members of the AbrC3 regulon: AbrC3 is a positive autoregulator which also binds to the promoter regions of SCO0736, bdtA (SCO3328), absR1 (SCO6992), and SCO6809. The direct targets share the 10-base consensus binding sequence and may be responsible for some of the phenotypes of the ΔabrC3 mutant. The identification of the AbrC3 regulon as part of the complex regulatory network governing antibiotic production widens our knowledge regarding TCS involvement in control of antibiotic synthesis and may contribute to the rational design of new hyperproducer host strains through genetic manipulation of such systems.

  • Archer SN, Laing EE, Möller-Levet CS, van der Veen DR, Bucca G, Lazar AS, Santhi N, Slak A, Kabiljo R, von Schantz M, Smith CP, Dijk DJ. (2014) 'Mistimed sleep disrupts circadian regulation of the human transcriptome.'. Proc Natl Acad Sci U S A, United States: 111 (6), pp. E682-E691.

    Abstract

    Circadian organization of the mammalian transcriptome is achieved by rhythmic recruitment of key modifiers of chromatin structure and transcriptional and translational processes. These rhythmic processes, together with posttranslational modification, constitute circadian oscillators in the brain and peripheral tissues, which drive rhythms in physiology and behavior, including the sleep-wake cycle. In humans, sleep is normally timed to occur during the biological night, when body temperature is low and melatonin is synthesized. Desynchrony of sleep-wake timing and other circadian rhythms, such as occurs in shift work and jet lag, is associated with disruption of rhythmicity in physiology and endocrinology. However, to what extent mistimed sleep affects the molecular regulators of circadian rhythmicity remains to be established. Here, we show that mistimed sleep leads to a reduction of rhythmic transcripts in the human blood transcriptome from 6.4% at baseline to 1.0% during forced desynchrony of sleep and centrally driven circadian rhythms. Transcripts affected are key regulators of gene expression, including those associated with chromatin modification (methylases and acetylases), transcription (RNA polymerase II), translation (ribosomal proteins, initiation, and elongation factors), temperature-regulated transcription (cold inducible RNA-binding proteins), and core clock genes including CLOCK and ARNTL (BMAL1). We also estimated the separate contribution of sleep and circadian rhythmicity and found that the sleep-wake cycle coordinates the timing of transcription and translation in particular. The data show that mistimed sleep affects molecular processes at the core of circadian rhythm generation and imply that appropriate timing of sleep contributes significantly to the overall temporal organization of the human transcriptome.

  • Möller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, Lo JC, Santhi N, von Schantz M, Smith CP, Dijk DJ. (2013) 'Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome.'. Proc Natl Acad Sci U S A, United States: 110 (12), pp. E1132-E1141.

    Abstract

    Insufficient sleep and circadian rhythm disruption are associated with negative health outcomes, including obesity, cardiovascular disease, and cognitive impairment, but the mechanisms involved remain largely unexplored. Twenty-six participants were exposed to 1 wk of insufficient sleep (sleep-restriction condition 5.70 h, SEM = 0.03 sleep per 24 h) and 1 wk of sufficient sleep (control condition 8.50 h sleep, SEM = 0.11). Immediately following each condition, 10 whole-blood RNA samples were collected from each participant, while controlling for the effects of light, activity, and food, during a period of total sleep deprivation. Transcriptome analysis revealed that 711 genes were up- or down-regulated by insufficient sleep. Insufficient sleep also reduced the number of genes with a circadian expression profile from 1,855 to 1,481, reduced the circadian amplitude of these genes, and led to an increase in the number of genes that responded to subsequent total sleep deprivation from 122 to 856. Genes affected by insufficient sleep were associated with circadian rhythms (PER1, PER2, PER3, CRY2, CLOCK, NR1D1, NR1D2, RORA, DEC1, CSNK1E), sleep homeostasis (IL6, STAT3, KCNV2, CAMK2D), oxidative stress (PRDX2, PRDX5), and metabolism (SLC2A3, SLC2A5, GHRL, ABCA1). Biological processes affected included chromatin modification, gene-expression regulation, macromolecular metabolism, and inflammatory, immune and stress responses. Thus, insufficient sleep affects the human blood transcriptome, disrupts its circadian regulation, and intensifies the effects of acute total sleep deprivation. The identified biological processes may be involved with the negative effects of sleep loss on health, and highlight the interrelatedness of sleep homeostasis, circadian rhythmicity, and metabolism.

  • Swiatek MA, Gubbens J, Bucca G, Song E, Yang YH, Laing E, Kim BG, Smith CP, van Wezel GP. (2013) 'The ROK-family regulator Rok7B7 pleiotropicaly affects xylose utilization, carbon catabolite repression and antibiotic production in Streptomyces coelicolor.'. J Bacteriol, 195 (6), pp. 1236-1248.

    Abstract

    Members of the ROK family of proteins are mostly transcriptional regulators and kinases that generally relate to the control of primary metabolism, whereby its member glucose kinase acts as the central control protein in carbon control in Streptomyces. Here we show that deletion of SCO6008 (rok7B7) strongly affects carbon catabolite repression (CCR), growth and antibiotic production in Streptomyces coelicolor. Deletion of SCO7543 also affected antibiotic production, while no major changes were observed after deletion of the rok family genes SCO0794, SCO1060, SCO2846, SCO6566 or SCO6600. Global expression profiling of the rok7B7 mutant by proteomics and microarray analysis revealed strong up-regulation of the xylose transporter operon xylFGH, which lies immediately downstream of rok7B7, consistent with the improved growth and delayed development of the mutant on xylose. The enhanced CCR, which was especially obvious on rich or xylose-containing media, correlated with elevated expression of glucose kinase and of the glucose transporter GlcP. In liquid-grown cultures, expression of the biosynthetic enzymes for production of prodigionines (Red), siderophores and calcium dependent antibiotic (Cda) was enhanced in the mutant, and overproduction of Red was corroborated by MALDI-ToF analysis. These data present Rok7B7 as a pleiotropic regulator of growth, CCR and antibiotic production in Streptomyces.

  • Salerno P, Persson J, Bucca G, Laing E, Ausmees N, Smith CP, Flärdh K. (2013) 'Identification of new developmentally regulated genes involved in Streptomyces coelicolor sporulation.'. BMC Microbiol, England: 13

    Abstract

    The sporulation of aerial hyphae of Streptomyces coelicolor is a complex developmental process. Only a limited number of the genes involved in this intriguing morphological differentiation programme are known, including some key regulatory genes. The aim of this study was to expand our knowledge of the gene repertoire involved in S. coelicolor sporulation.

  • Thomas SA, Jin Y, Laing E, Smith CP. (2013) 'Reconstructing regulatory networks in Streptomyces using evolutionary algorithms'. 2013 13th UK Workshop on Computational Intelligence, UKCI 2013, , pp. 24-30.

    Abstract

    Reconstructing biological networks is vital in developing our understanding of nature. Biological systems of particular interest are bacteria that can produce antibiotics during their life cycle. Such an organism is the soil dwelling bacterium Streptomyces coelicolor. Although some of the genes involved in the production of antibiotics in the bacterium have been identified, how these genes are regulated and their specific role in antibiotic production is unknown. By understanding the network structure and gene regulation involved it may be possible to improve the production of antibiotics from this bacterium. Here we use an evolutionary algorithm to optimise parameters in the gene regulatory network of a sub-set of genes in S. coelicolor involved in antibiotic production. We present some of our preliminary results based on real gene expression data for continuous and discrete modelling techniques. © 2013 IEEE.

  • Allenby NE, Laing E, Bucca G, Kierzek AM, Smith CP. (2012) 'Diverse control of metabolism and other cellular processes in Streptomyces coelicolor by the PhoP transcription factor: genome-wide identification of in vivo targets.'. Nucleic Acids Res,

    Abstract

    Streptomycetes sense and respond to the stress of phosphate starvation via the two-component PhoR-PhoP signal transduction system. To identify the in vivo targets of PhoP we have undertaken a chromatin-immunoprecipitation-on-microarray analysis of wild-type and phoP mutant cultures and, in parallel, have quantified their transcriptomes. Most (ca. 80%) of the previously in vitro characterized PhoP targets were identified in this study among several hundred other putative novel PhoP targets. In addition to activating genes for phosphate scavenging systems PhoP was shown to target two gene clusters for cell wall/extracellular polymer biosynthesis. Furthermore PhoP was found to repress an unprecedented range of pathways upon entering phosphate limitation including nitrogen assimilation, oxidative phosphorylation, nucleotide biosynthesis and glycogen catabolism. Moreover, PhoP was shown to target many key genes involved in antibiotic production and morphological differentiation, including afsS, atrA, bldA, bldC, bldD, bldK, bldM, cdaR, cdgA, cdgB and scbR-scbA. Intriguingly, in the PhoP-dependent cpk polyketide gene cluster, PhoP accumulates substantially at three specific sites within the giant polyketide synthase-encoding genes. This study suggests that, following phosphate limitation, Streptomyces coelicolor PhoP functions as a 'master' regulator, suppressing central metabolism, secondary metabolism and developmental pathways until sufficient phosphate is salvaged to support further growth and, ultimately, morphological development.

  • Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hyppönen E, Berry J, Vieth R, Lanham-New S. (2012) 'Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis.'. Am J Clin Nutr, United States: 95 (6), pp. 1357-1364.

    Abstract

    Currently, there is a lack of clarity in the literature as to whether there is a definitive difference between the effects of vitamins D(2) and D(3) in the raising of serum 25-hydroxyvitamin D [25(OH)D].

  • Thirlway J, Lewis R, Nunns L, Al Nakeeb M, Styles M, Struck A-W, Smith CP, Micklefield J. (2012) 'Introduction of a Non-Natural Amino Acid into a Nonribosomal Peptide Antibiotic by Modification of Adenylation Domain Specificity'. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 51 (29), pp. 7181-7184.
  • Lewis RA, Shahi SK, Laing E, Bucca G, Efthimiou G, Bushell M, Smith CP. (2011) 'Genome-wide transcriptomic analysis of the response to nitrogen limitation in Streptomyces coelicolor A3(2).'. BMC Res Notes, England: 4
  • Lewis RA, Nunns L, Thirlway J, Carroll K, Smith CP, Micklefield J. (2010) 'Active site modification of the beta-ketoacyl-ACP synthase FabF3 of Streptomyces coelicolor affects the fatty acid chain length of the CDA lipopeptides'. CHEMICAL COMMUNICATIONS, 47 (6), pp. 1860-1862.
  • Laing E, Smith CP. (2010) 'RankProdIt: A web-interactive Rank Products analysis tool.'. BMC Res Notes, England: 3
  • Lewis RA, Laing E, Allenby N, Bucca G, Brenner V, Harrison M, Kierzek AM, Smith CP. (2010) 'Metabolic and evolutionary insights into the closely-related species Streptomyces coelicolor and Streptomyces lividans deduced from high-resolution comparative genomic hybridization.'. BMC Genomics, England: 11

    Abstract

    Whilst being closely related to the model actinomycete Streptomyces coelicolor A3(2), S. lividans 66 differs from it in several significant and phenotypically observable ways, including antibiotic production. Previous comparative gene hybridization studies investigating such differences have used low-density (one probe per gene) PCR-based spotted arrays. Here we use new experimentally optimised 104,000 × 60-mer probe arrays to characterize in detail the genomic differences between wild-type S. lividans 66, a derivative industrial strain, TK24, and S. coelicolor M145.

  • Salerno P, Larsson J, Bucca G, Laing E, Smith CP, Flardh K. (2009) 'One of the Two Genes Encoding Nucleoid-Associated HU Proteins in Streptomyces coelicolor Is Developmentally Regulated and Specifically Involved in Spore Maturation'. JOURNAL OF BACTERIOLOGY, 191 (21), pp. 6489-6500.
  • Sooriakumaran P, Macanas-Pirard P, Bucca G, Henderson A, Langley SE, Laing RW, Smith CP, Laing EE, Coley HM. (2009) 'A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.'. Cancer Genomics Proteomics, Greece: 6 (2), pp. 93-99.

    Abstract

    We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.

  • de Jong W, Manteca A, Sanchez J, Bucca G, Smith CP, Dijkhuizen L, Claessen D, Wosten HAB. (2009) 'NepA is a structural cell wall protein involved in maintenance of spore dormancy in Streptomyces coelicolor'. MOLECULAR MICROBIOLOGY, 71 (6), pp. 1591-1603.
  • Bucca G, Laing E, Mersinias V, Allenby N, Hurd D, Holdstock J, Brenner V, Harrison M, Smith CP. (2009) 'Development and application of versatile high density microarrays for genome-wide analysis of Streptomyces coelicolor: characterization of the HspR regulon'. GENOME BIOLOGY, 10 (1) Article number ARTN R5
  • Kim YJ, Moon MH, Song JY, Smith CP, Hong S-K, Chang YK. (2008) 'Acidic pH shock induces the expressions of a wide range of stress-response genes'. BMC GENOMICS, 9 Article number ARTN 604
  • Borodina I, Siebring J, Zhang J, Smith CP, van Keulen G, Dijkhuizen L, Nielsen J. (2008) 'Antibiotic overproduction in Streptomyces coelicolor A3(2) mediated by phosphofructokinase deletion'. JOURNAL OF BIOLOGICAL CHEMISTRY, 283 (37), pp. 25186-25199.
  • Kim YJ, Song JY, Hong S-K, Smith CP, Chang YK. (2008) 'Effects of pH shock on the secretion system in Streptomyces coelicolor A3(2)'. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 18 (4), pp. 658-662.
  • Kim YJ, Song JY, Moon MH, Smith CP, Hong S-K, Chang YK. (2007) 'pH shock induces overexpression of regulatory and biosynthetic genes for actinorhodin productionin Streptomyces coelicolor A3(2)'. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 76 (5), pp. 1119-1130.
  • Khanin R, Vinciotti V, Mersinias V, Smith CP, Wit E. (2007) 'Statistical reconstruction of transcription factor activity using Michaelis-Menten kinetics'. BIOMETRICS, 63 (3), pp. 816-823.
  • Hesketh A, Bucca G, Laing E, Flett F, Hotchkiss G, Smith CP, Chater KF. (2007) 'New pleiotropic effects of eliminating a rare tRNA from Streptomyces coelicolor, revealed by combined proteomic and transcriptomic analysis of liquid cultures'. BMC GENOMICS, 8 Article number ARTN 261
  • Noens EE, Mersinias V, Willemse J, Traag BA, Laing E, Chater KF, Smith CP, Koerten HK, van Wezel GP. (2007) 'Loss of the controlled localization of growth stage-specific cell-wall synthesis pleiotropically affects developmental gene expression in an ssgA mutant of Streptomyces coelicolor'. MOLECULAR MICROBIOLOGY, 64 (5), pp. 1244-1259.
  • Neary JM, Powell A, Gordon L, Milne C, Flett F, Wilkinson B, Smith CP, Micklefield J. (2007) 'An asparagine oxygenase (AsnO) and a 3-hydroxyasparaginyl phosphotransferase (HasP) are involved in the biosynthesis of calcium-dependent lipopeptide antibiotics'. MICROBIOLOGY-SGM, 153, pp. 768-776.
  • Powell A, Amir-Heidari B, Neary JM, Thirlway J, Micklefield J, Borg M, Smith CP, Wilkinson B. (2007) 'Engineered biosynthesis of nonribosomal lipopeptides with modified fatty acid side chains'. Journal of the American Chemical Society, 129 (49), pp. 15182-15192.

    Abstract

    The biological properties of the calcium-dependent antibiotics (CDAs), daptomycin and related nonribosomal lipopeptides, depend to a large extent on the nature of the N-terminal fatty acid moiety. It is suggested that the chain length of the unusually short (C6) 2,3-epoxyhexanoyl fatty acid moiety of CDA is determined by the specificity of the KAS-II enzyme encoded by fabF3 in the CDA biosynthetic gene cluster. Indeed, deletion of the downstream gene hxcO results in three new lipopeptides, all of which possess hexanoyl side chains (hCDAs). This confirms that HxcO functions as a hexanoyl-CoA or -ACP oxidase. The absence of additional CDA products with longer fatty acid groups further suggests that the CDA lipid chain is biosynthesized on a single ACP and is then transferred directly from this ACP to the first CDA peptide synthetase (CdaPS1). Interestingly, the hexanoyl-containing CDAs retain antibiotic activity. To further modulate the biological properties of CDA by introducing alternative fatty acid groups, a mutasynthesis approach was developed. This involved mutating the key active site Ser residue of the CdaPSI, module 1 PCP domain to Ala, which prevents subsequent phosphopantetheinylation. In the absence of the natural module 1 PCP tethered intermediate, it is possible to effect incorporation of different N-acyl-L-serinyl N-acetylcysteamine (NAC) thioester analogues, leading to CDA products with pentanoyl as well as hexanoyl side chains. © 2007 American Chemical Society.

  • Laing E, Mersinias V, Smith CP, Hubbard SJ. (2006) 'Analysis of gene expression in operons of Streptomyces coelicolor'. GENOME BIOLOGY, 7 (6) Article number ARTN R46
  • Milne C, Powell A, Al Nakeeb M, Micklefield J, Jim J, Smith CP. (2006) 'Biosynthesis of the (2S,3R)-3-methyl glutamate residue of nonribosomal lipopeptides'. Journal of the American Chemical Society, 128 (34), pp. 11250-11259.

    Abstract

    The calcium-dependent antibiotics (CDAs) and daptomycin are therapeutically relevant nonribosomal lipopeptide antibiotics that contain penultimate C-terminal 3-methyl glutamate (3-MeGlu) residues. Comparison with synthetic standards showed that (2S,3R)-configured 3-MeGlu is present in both CDA and daptomycin. Deletion of a putative methyltransferase gene glmT from the cda biosynthetic gene cluster abolished the incorporation of 3-MeGlu and resulted in the production of Glu-containing CDA exclusively. However, the 3-MeGlu chemotype could be re-established through feeding synthetic 3-methyl-2- oxoglutarate and (2S,3R)-3-MeGlu, but not (2S,3S)-3-MeGlu. This indicates that methylation occurs before peptide assembly, and that the module 10 A-domain of the CDA peptide synthetase is specific for the (2S,3R)-stereoisomer. Further mechanistic analyses suggest that GlmT catalyzes the SAM-dependent methylation of α-ketoglutarate to give (3R)-methyl-2-oxoglutarate, which is transaminated to (2S,3R)-3-MeGlu. These insights will facilitate future efforts to engineer lipopeptides with modified glutamate residues, which may have improved bioactivity and/or reduced toxicity. © 2006 American Chemical Society.

  • D'Alimonte D, Lowe D, Nabney IT, Mersinias V, Smith CP. (2005) 'MILVA: An interactive tool for the exploration of multidimensional microarray data'. BIOINFORMATICS, 21 (22), pp. 4192-4193.
  • Noens EEE, Mersinias V, Traag BA, Smith CP, Koerten HK, van Wezel GP. (2005) 'SsgA-like proteins determine the fate of peptidoglycan during sporulation of Streptomyces coelicolor'. MOLECULAR MICROBIOLOGY, 58 (4), pp. 929-944.
  • Takano E, Kinoshita H, Mersinias V, Bucca G, Hotchkiss G, Nihira T, Smith CP, Bibb M, Wohlleben W, Chater K. (2005) 'A bacterial hormone (the SCB1) directly controls the expression of a pathway-specific regulatory gene in the cryptic type I polyketide biosynthetic gene cluster of Streptomyces coelicolor'. MOLECULAR MICROBIOLOGY, 56 (2), pp. 465-479.
  • Vinciotti V, Khanin R, D'Alimonte D, Liu X, Cattini N, Hotchkiss G, Bucca G, de Jesus O, Rasaiyaah J, Smith CP, Kellam P, Wit E. (2005) 'An experimental evaluation of a loop versus a reference design for two-channel microarrays'. BIOINFORMATICS, 21 (4), pp. 492-501.
  • Uguru GC, Milne C, Borg M, Flett F, Smith CP, Micklefield J. (2004) 'Active-site modifications of adenylation domains lead to hydrolysis of upstream nonribosomal peptidyl thioester intermediates'. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 126 (16), pp. 5032-5033.
  • Bucca G, Brassington AME, Hotchkiss G, Mersinias V, Smith CP. (2003) 'Negative feedback regulation of dnaK, clpB and lon expression by the DnaK chaperone machine in Streptomyces coelicolor, identified by transcriptome and in vivo DnaK-depletion analysis'. MOLECULAR MICROBIOLOGY, 50 (1), pp. 153-166.

Conference papers

  • Bucca G, Carruba G, Saetta A, Muti P, Castagnetta M, Smith CP, Bradlow HL, Castagnetta L, Massimo L, Zaenker K. (2004) 'Gene expression profiling of human cancers'. NEW YORK ACAD SCIENCES SIGNAL TRANSDUCTION AND COMMUNICATION IN CANCER CELLS, Erice, ITALY: Conference on Signal Transduction and Communication in Cancer Cells 1028, pp. 28-37.

Teaching

Undergraduate

Molecular Biology and Genetics – Level 1 (Module co-ordinator)

Molecular Biology and Genetics – Level 2

Molecular Biology and Genetics – Level 3

Microbiology Systems – Level 2

Postgraduate

MSc Medical Microbiology (MMIM018) Module: Microbial Genetics and Molecular biology

Departmental Duties

Faculty Research Strategy Leader for Systems Biology

Academic lead: Core Microarray Facility

Member: Faculty Research Committee

Resources

DNA microarray resource

For information on availability of DNA microarrays and their use please access: The Streptomyces coelicolor Microrray Resource

Page Owner: bss2cs
Page Created: Tuesday 9 June 2009 15:46:45 by t00345
Last Modified: Thursday 16 October 2014 16:56:04 by bss2cs
Assembly date: Wed Oct 22 17:50:02 BST 2014
Content ID: 6216
Revision: 10
Community: 1196